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ABSTRACT: Bovine and human insulin have similar primary structures. In this
article, the region of the insulin A-chain of bovine and human insulin where the amino
acid composition is different was studied. Bovine insulin fragment (BIF) and human
insulin fragment (HIF) were synthesized in solid-phase peptide synthesis. The effects
of pH, temperature, urea, ionic strength, and stirring on the formation of fibrils were
studied using a fractional factorial resolution III experimental design. Fibrillation was
monitored by fluorescence and infrared spectroscopy and optical microscopy. Both
fragments formed fibrils at pH 1.6 and a temperature of 60 °C. The lag time and
apparent aggregation growth rate constant were determined using a two-parameter
kinetic model. It was found that the bovine insulin fragment has a shorter lag time than
the human insulin one, whereas the exponential phase rate was faster for HIF than for
BIF. An increase in β-sheets content with time was observed in both fragments. The
increase in β-sheets was preceded by an initial decrease in α-helices followed by an
intermediate increase during the transition from the lag phase to elongation phase.
Temperature and ionic strength are among the most important experimental factors during the lag phase, whereas ionic strength
is replaced by pH during the elongation phase for both the fragments. Congo red binding confirmed the presence of ringlike
oligomer structures rich in antiparallel β-sheets, which tend to form fibrils rich in parallel β-sheets.
■ INTRODUCTION
Protein aggregation is a major problem found in the
bioprocessing industry. Aggregation can occur at any step,
from production to purification and packing.1 Protein
therapeutics might lose their biological activity and cause
problems during treatment if they aggregate. Proteins can form
aggregates both in their native and denatured state. They can
aggregate either during the lyophilization step or during their
long-term storage. Aggregation also happens during the
unfolding/refolding reaction in the production of recombinant
proteins.
Protein aggregation in vivo is associated with disease.
Formation of amyloid fibrils is the manifestation of various
amyloidogenic diseases like Alzheimer’s, neurofibrillary tangle,
neurodegeneration, Parkinson’s, etc. A total of 36 proteins/
peptides has been identified to form amyloid fibrils in vivo till
2016.2 Amyloid fibrils are β-sheet rich linear aggregates formed
from circular oligomers. X-ray diffraction of amyloid fibrils
shows a cross β diffraction pattern, which is a trademark of
intermolecular β-sheet structures.3−6 This intermolecular β-
sheet structure is easily identified by Fourier transform infrared
spectroscopy (FTIR). It has been recently proved that
oligomers are the elemental blocks to build a fibril.7,8 The
propensity to form amyloid fibrils seems to be correlated with
the hydrophobicity of proteins.9 In spite of their association
with disease, amyloid aggregates can also be used as scaffolds,
as peptide hormones storage and natural adhesives.10
Although amyloid fibrils are mostly related to disease
causing proteins, it was also reported that if appropriate
incubation conditions were provided even a nonpathogenic
protein can form a fibrillar structure.11 Fibrils can also be
synthesized in vitro by subjecting the protein to favorable
destabilizing conditions.12,13 For example, hen lysozyme
incubated at pH 2.0 and 37 °C forms fibrils.14
Insulin aggregates at acidic pH and high temperature.15
Insulin is a highly conserved hormone exhibiting minor
differences in the amino acid sequence from species to species.
For instance, Ala replaces Thr at position 8, Val replaces Ile at
position 10, and Ala replaces Thr at position 30 in bovine and
human insulins, respectively.16 Our previous studies showed
that the aggregation kinetics (both lag times and rate
constants) is very different for bovine and human insulin.17
Moreover, dynamic light scattering and FTIR experiments
showed that both insulins seem to follow different aggregation
pathways as shown by different populations of aggregate sizes
and different secondary structure changes. Still, mature fibrils
were practically identical. Previously, it was demonstrated that
the B chain fragment LVEALYL plays a key role in
aggregation.18 A recent review shows that different insulin
analogs show different aggregation pathways.19 In an attempt
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to identify the causes for those differences in the aggregation
kinetics, we decided to study fragments of the insulin A-chain
containing the sequence where bovine and human insulins are
different.16 Insulin A-chain is a 21-residue peptide, in which
only the amino acids at positions 8 and 10 differ for bovine and
human insulins.20 Bovine insulin has alanine and valine at
positions 8 and 10, whereas human insulin has threonine and
isoleucine. We selected the sequences ASVCSLYQLENK3
(bovine insulin fragment (BIF)) and TSICSLYQLENK3
(human insulin fragment (HIF)) for the bovine and human
fragments, respectively. Bold letters identify the amino acids
that are different in both fragments. A lysine tail was added to
each fragment to increase its solubility.21
To study the effects of temperature, urea, ionic strength, pH,
and stirring on the fibrillation process, a screening
experimental design was chosen. The factors were chosen
based on the following criteria. Temperature affects protein
folding and therefore the formation of the nuclei. Urea, a
known chaotropic, was chosen to study the effect of water
structure on fibril formation. Ionic strength and pH affect
coulombic interactions among the side chains of amino acids,
which affects fibrillation. Interfaces (solid/liquid or gas/liquid)
induce protein aggregation. Air was incorporated into samples
by stirring to study the effect of gas/liquid interfaces on
fibrillation. The evolution of the aggregation process with time
was monitored using a thioflavin T (ThT) fluorescence assay.
Secondary structure changes were monitored using attenuated
total reflection (ATR)-FTIR spectroscopy. The presence of
Congo red stained fibrils22 was confirmed by light microscopy.
pH, temperature, urea, ionic strength and stirring were
chosen as factors for the experimental design. A two-level
fractional factorial design FF0508 of resolution III as shown in
Table 1 consisting of five factors at two levels each with a total
of 8 runs was chosen. Each main effect in this design was
confounded with one or more two-factor interactions. The
lower and higher levels chosen for the factors are shown in
Table 2.
■ RESULTS AND DISCUSSION
The amino acid composition of both BIF and HIF was
determined using 1H NMR spectroscopy. 1H resonance
assignments for each amino acid were done based on its
corresponding proton chemical shifts. All of the data related to
proton chemical shifts were obtained from the Biological
Magnetic Resonance Data Bank.23 Figure 1A,B shows the full
1H NMR spectra for BIF and HIF, respectively, with their
corresponding amino acid resonance assignments for various
protons. Both spectra look similar with a few minor differences
in the peaks at the backbone and the sidechain regions. Figure
1A has peaks at 4.25, 1.35, 4.17, and 2.28 ppm, which
correspond to Ala Hα, Ala Hβ, Val Hα, and Val Hβ and seen
only in BIF. Similarly, Figure 1B has peaks at 4.38, 4.11, 3.99,
and 1.78 ppm, which correspond to Thr Hα, Thr Hβ, Ile Hα,
and Ile Hβ, respectively, and seen in only HIF. Peaks assigned
to rest of the amino acids are same in both the fragments
(Tables S1 and S2).
The purity and mass of both peptide fragments were
calculated from the liquid chromatography−mass spectrometry
(LC−MS) data obtained using a quadrupole time-of-flight (Q-
TOF) LC−MS system. Figures S11 and S12 show the relative
abundance and mass for native BIF and HIF, respectively. The
purity of the samples was calculated based on the relative
abundance of each fraction. BIF full intact peptide (one to
three lysines at the tail) has a purity of 72%. The major
impurity found in both peptides is a fluorenylmethyloxycar-
bonyl chloride (Fmoc) group (mass of 164 Da) due to an
inefficient final deprotection step. Fmoc-attached peptide
(impurity) is ∼28% in BIF, whereas it is ∼66% in HIF (53%
Fmoc full peptide plus 13% Fmoc with no Thr). Since the
peptides were used without further purification, it is important
to determine the composition of the fibrils obtained in the
experiment using LC−MS to estimate the effect of the
impurity on fibrillation. Four samples, one with high β-sheet
content (pH 1.6, 60 °C, 1 M urea, 0.02 M NaCl) and the other
with low β-sheet content (pH 5, 25 °C, 1 M urea, 0.02 M
NaCl) for both BIF and HIF, were chosen for this analysis.
Aggregates formed at pH 5 and 25 °C in both the fragments
consist of 93% Fmoc (BIF)- and 100% HIF-attached peptide
in abundance, as shown in Figures S13B and S14B, whereas at
pH 1.6 and 60 °C, fibrils in BIF consist of equal amounts of
native and Fmoc-attached peptide, but HIF fibrils are made of
74% Fmoc HIF, 22% truncated Fmoc HIF, and only 4% HIF
(Figures S13A and S14A). Finally, both BIF and HIF at pH 1.6
and 60 °C show deamidation of Asn to Asp, but this is not
observed at pH 5 and 25 °C. Deamidation is favored by low
pH and high temperature. It is not clear if deamidation
occurred before, during or after the formation of the
aggregates. Deamidation may occur by acid/base catalysis as
well as by intramolecular nucleophilic catalysis.
One commonly used mechanism to explain fibril formation
consists of three phases: (1) nucleation/lag, (2) elongation/
exponential growth, and (3) equilibrium/precipitation.24 The
process begins with a lag phase where there is no significant
change in the soluble peptide concentration. Nuclei/oligomer
structures are formed by partly denatured peptides.25,26 The
lag phase is followed by an elongation or the exponential
growth phase where the size of the fibrils increases by addition
of preformed oligomer structures to protofilaments.27,28
Finally, it reaches an equilibrium/precipitation phase where
most of the soluble peptide have been converted into fibrils.
Table 1. Experimental Design FF0508
run pH temp. (°C) urea (M) ionic (M) stirring
1 − − − − +
2 − − + + −
3 − + − + −
4 − + + − +
5 + − − + +
6 + − + − −
7 + + − − −
8 + + + + +
Table 2. Experimental Factors with Lower and Higher levels
factor − +
pH 1.6 5
temperature (°C) 25 60
urea (M) 0 1
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The process of fibril formation was studied using ThT
fluorescence assay, and the changes in the secondary structure
were simultaneously determined using ATR-FTIR. ThT bound
to amyloid-like fibrils shows a strong fluorescent signal.29 ThT
dye does not bind to either soluble peptides or to amorphous
aggregates.30 ThT-induced spectral changes for various
amyloidogenic proteins are qualitatively identical irrespective
of the primary structure, this feature is important when
comparing two slightly different peptides (Table 1 and 2).31
Figures 2 and 3 show relative fluorescence versus time at all
experimental conditions for BIF and HIF, respectively.
Representative error bars are included in both figures. Most
curves show a characteristic sigmoidal shape consisting of three
regions: a lag phase, an exponential phase, and an equilibrium
phase. Therefore, the kinetics of fibril formation can be
characterized by a lag time (tlag) and an apparent aggregation
growth rate constant (Kapp). The obtained sigmoidal curves for
each run were curve fitted using nonlinear curve fit in Origin






1 e x x dx( )/0 (1)
where y is the fluorescence intensity for the normalized data, x
is the time in days, x0 is the time at 50% fluorescence intensity,
and dx is the time constant. From eq 1 the lag time (tlag) and
apparent aggregation growth rate constant (Kapp) can be
calculated using tlag = (x0 − 2dx) and Kapp = 1/dx. The
calculated lag time (tlag) and apparent aggregation growth rate
constants (Kapp) for both BIF and HIF are shown in Table 3.
All of the runs for BIF formed fibrils, whereas two of the eight
Figure 1. (A) 1H NMR spectrum of the peptide fragments in their native state at 25 °C. Full 1H NMR spectrum of BIF highlighting the chemical
shifts corresponding to alanine and valine. (B) 1H NMR spectrum of the peptide fragments in their native state at 25 °C. Full 1H NMR spectrum of
HIF highlighting the chemical shifts corresponding to threonine and isoleucine.
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runs for HIF (pH 1.6, 25 °C, 1 M urea, 1 M NaCl; pH 5, 25
°C, 1 M urea, 0.02 M NaCl) are still in the lag phase after 8
weeks. This finding suggests that HIF does not form nuclei at
room temperature in the presence of urea irrespective of the
other conditions. In contrast, HIF at room temperature in the
absence of urea (pH 1.6, 25 °C, 0 M urea, 0.02 M NaCl; pH 5,
25 °C, 0 M urea, 1 M NaCl) forms fibrils.
BIF has shorter lag times than HIF under all incubation
conditions. The lag times are shorter at higher temperatures
under all conditions for both BIF and HIF. This dependence
on temperature was also observed in native bovine and human
insulins.17 Though the lag times are shorter for BIF than HIF
(at the same conditions), the rate of aggregation is faster for
HIF than BIF except for run #1 (Table 1). The lag time is the
shortest for BIF at pH 5, 60 °C, no urea, 0.02 M NaCl (7 ± 1
days) and it is the longest for BIF at pH 1.6, 25 °C, 1 M urea, 1
M NaCl (16 ± 1 days). For HIF, lag time is the shortest at pH
5, 25 °C, 0 M urea, 1 M NaCl (13 ± 2 days), whereas it is the
longest at pH 1.6, 25 °C, 0 M urea, 0.02 M NaCl (30 ± 2
days). At 1 M urea and 0.02 M NaCl, samples at the lowest pH
and highest temperature (BIF and HIF at pH 1.6, 60 °C) have
a shorter lag time than samples at the highest pH and lowest
temperature (BIF and HIF at pH 5, 25 °C).
Pareto charts using tlag or Kapp as an outcome are shown in
Figures 4 and 5, respectively. The important factors using each
outcome were identified using the Pareto principle.33 The
important factors during lag phase are temperature, ionic
strength, and urea for BIF, whereas for HIF, temperature, pH,
and ionic strength are significant. Although all of the factors
seem to be important during the elongation phase for HIF,
temperature and pH are the most important ones, which is also
true for BIF. The pH is of importance during elongation phase
as it affects the interactions among the side chains of amino
acids leading to the formation of fibrils. The presence of gas/
liquid interfaces has a negligible effect on fibrillation.
Exposure of hydrophobic surfaces to water plays an
important role in the formation of fibrils.34 Hydrophobicity
of each amino acid residue can be assigned from the native
structure according to the hydrophobicity scales of Kyte and
Doolittle in the UCSF Chimera package.35,36 The native
peptide structures were generated using a web server PEP-
FOLD3.37 The structures shown in Figure 6A,B correspond to
BIF and HIF. Models were visualized using the UCSF Chimera
package.36 The residues in each peptide are shown in various
colors according to their hydrophobicity. Colors range from
blue for the most hydrophilic to white (neutral) to orange for
the most hydrophobic. BIF has alanine and valine, which are
replaced by threonine and isoleucine in HIF at their respective
positions. Comparing the hydrophobicity indexes, alanine
(47), valine (79), and isoleucine (99) are very hydrophobic
amino acids at both acidic and basic pHs compared to
threonine, which is a neutral amino acid (13).38 The presence
of an extra hydrophobic residue for BIF over HIF could be the
reason for shorter lag times observed with BIF. However, BIF
shows a slower growth rate than HIF. This suggests that the
nuclei of both peptides are structurally different.
The formation of intermolecular β-sheet secondary structure
is one criterion used to label an aggregate as an “amyloid
fibril”.22 The changes in the secondary structure of peptides
can be followed by FTIR.39 Moreover, ATR-FTIR plays a
prominent role in differentiating the oligomers (antiparallel β-
Figure 2. ThT fluorescence plots showing the fibril formation process
with time for BIF at pH 1.6, 25 °C, 0 M urea, 0.02 M NaCl (−■−);
pH 1.6, 25 °C, 1 M urea, 1 M NaCl (−●−); pH 1.6, 60 °C, 0 M urea,
1 M NaCl (−▲−); pH 1.6, 60 °C, 1 M urea, 0.02 M NaCl (−▼−);
pH 5, 25 °C, 0 M urea, 1 M NaCl (−⧫−); pH 5, 25 °C, 1 M urea,
0.02 M NaCl (−◀−); pH 5, 60 °C, 0 M urea, 0.02 M NaCl (−▶−);
pH 5, 60 °C, 1 M urea, 1 M NaCl (−⬢−).
Figure 3. ThT fluorescence plots showing the fibril formation process
with time for HIF at pH 1.6, 25 °C, 0 M urea, 0.02 M NaCl (−■−);
pH 1.6, 25 °C, 1 M urea, 1 M NaCl (−●−); pH 1.6, 60 °C, 0 M urea,
1 M NaCl (−▲−); pH 1.6, 60 °C, 1 M urea, 0.02 M NaCl (−▼−);
pH 5, 25°C, 0 M urea, 1 M NaCl (−⧫−); pH 5, 25 °C, 1 M urea, 0.02
M NaCl (−◀−); pH 5, 60 °C, 0 M urea, 0.02 M NaCl (−▶−); pH
5, 60 °C 1 M urea, 1 M NaCl (−⬢−).
Table 3. Lag Times (tlag) and Apparent Aggregation Growth
Rate Constants (Kapp) Calculated for Both BIF and HIF
bovine human
run # tlag (days) Kapp (day
−1) tlag (days) Kapp (day
−1)
1 12 ± 1 0.85 ± 0.37 30 ± 2 0.18 ± 0.02
2 16 ± 1 0.53 ± 0.16
3 12 ± 1 0.51 ± 0.10 22 ± 1 0.62 ± 0.07
4 11 ± 2 0.22 ± 0.05 24 ± 2 0.47 ± 0.16
5 14 ± 1 0.94 ± 0.13 13 ± 2 0.99 ± 0.63
6 14 ± 2 1.51 ± 0.15
7 7 ± 1 0.29 ± 0.04 20 ± 1 0.70 ± 0.17
8 11 ± 2 0.57 ± 0.22 15 ± 1 0.73 ± 0.18
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sheets) from fibrils (parallel β-sheets).40 Therefore, IR
spectroscopy is an alternative method to complex techniques
like X-ray diffraction.41 Second-derivative analysis of the
spectra allows the determination of protein secondary
structure.42 The number of peaks from the deconvolved
spectra should be chosen carefully. It is necessary to confirm
that the maximum frequency of the curve-fit peaks corresponds
to the maxima evident in the raw data to ensure that the peak
is assigned to its specific secondary structure.43 The precision
of the calculated peak areas from the second-derivative spectra
largely depends on the baseline chosen while fitting.39 Origin
Pro peak fit analysis has various baseline modes for this
purpose.
The relevant region in the spectra is the amide I region
(1600−1700 cm−1), which is caused by the carbonyl group
stretching vibrations from the peptide backbone.44 Each
structural conformation has a unique CO vibration depend-
ent on its hydrogen bonding pattern.45 One major limitation
with the spectra is that the amide I peak has a maximum at
∼1650 cm−1 that coincides with the water maximum
absorption at ∼1643 cm−1. The water background needs to
be carefully subtracted from the spectra. The use of an ATR
attachment avoids this problem and allows data collection with
minimal use of sample.46 A flat baseline obtained between
2200 and 1800 cm−1 is often considered a standard to confirm
proper water subtraction.47 Absorption of the side chains also
causes spectral deviation during the analysis. Carbonyl group
vibrations for asparagine and glutamine occur at around 1678
and 1670 cm−1, which can affect the spectra.48 Urea also has an
absorption peak in the amide I region, which can be
deceptive.49 Hence, during the background subtraction for
the samples in the presence of urea, 20 μL of 1 M urea was
added to the blank to subtract the undesired peaks.
FTIR analysis of the native peptide fragments shows an α-
helix content of 52.6 and 53.9% for BIF and HIF, respectively,
whereas the rest of the structure is random coils (Figures S1
and S2). The calculated secondary structures for both peptides
predicted by PEP-FOLD3 are 42.9 and 64.3% α-helix for both
BIF and HIF (the rest being random coils). The secondary
structure is calculated using DSSP, a hydrogen bond
estimation based algorithm by the secondary structure server.50
Figure 4. Pareto charts showing the effects of various factors based on
tlag as an outcome from the experimental design FF0508 for (A) BIF
and (B) HIF. Prominent factors are highlighted using the dotted line.
Figure 5. Pareto charts showing the effects of various factors based on
Kapp as an outcome from the experimental design FF0508 for (A) BIF
and (B) HIF. Prominent factors are highlighted using the dotted line.
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PSIPRED and Porter 4.0 protein servers also confirmed that
both the peptides consist of α-helices and random coils.51
Comparing the experimental and theoretical values of α-helix
content, BIF has ∼82% Q3 accuracy, whereas HIF has ∼81%
Q3 accuracy, which are acceptable.52
Figure 7A shows the FTIR spectra of BIF at pH 1.6, 60 °C, 1
M urea, and 0.02 M NaCl collected during weeks 1 and 6. At
time 0, the amide I peak is centered at 1650 cm−1, but after 42
days the peak shifted to 1681 cm−1. This net band shift
corresponds to an α-helix to β-sheet transition with time.53 By
curve fitting the deconvoluted spectra, the amount of each
secondary structure was determined, as shown in Figure 7B,
which corresponds to BIF at the above conditions during week
1. The integration of each curve-fitted peak yields the total
secondary structure content. At the end of week 1 (Figure 7B),
three peaks are found around 1635, 1663, and 1689 cm−1. The
bands around 1635 and 1689 cm−1 correspond to β-sheets/
random coil and turns/antiparallel β-sheets, respectively,
whereas the peak around 1663 cm−1 can be assigned to α-
helix. At the end of week 6, four peaks around 1620, 1651,
1674, and 1681 cm−1 are found. The peak at 1635 cm−1 during
week 1 vanishes with time, and the presence of a peak around
1620 cm−1 during week 6 corresponds to an increase in β-sheet
content. Researchers previously reported that the fibrils show a
new β band at ∼1620 cm−1 as opposed to the native FTIR β
band at ∼1635 cm−1.54 The peaks at 1620 and 1651 cm−1 can
be assigned to extended β-sheets and α-helix, whereas the
other two peaks correspond to β-turns/antiparallel β-sheets.
Similar analysis was also conducted on HIF, and the secondary
structure content was determined (Figure S3A,B). HIF peaks
were located around same wavenumbers as that of BIF (Table
S3).
Figures 8 and 9 show plots for the change in the
intermolecular β-sheet content with time for both BIF and
HIF, respectively. All of the runs show an increase in the
percentage of β-sheets with time. All BIF samples have a higher
percentage of β-sheets than HIF when incubated at the same
conditions. The highest percentage of β-sheets was found in
BIF (34%) and HIF (31%) at pH 1.6, 60 °C, 1 M urea, 0.02 M
NaCl. HIF at 60 °C for all runs has a higher percentage when
compared to the one at 25 °C. As it is evident from the plots,
most of the increase in β-sheets occurred in the first 2 weeks of
the experiment for BIF and in the first 3 weeks for HIF. A
Figure 6. Model peptide fragments visualized using UCSF chimera
package with variations in colors according to their hydrophobicity
(blue: most hydrophilic, white: neutral, orange: most hydrophobic).
(A) BIF has alanine and valine, which are both hydrophobic and (B)
HIF has threonine which is neutral and isoleucine which is
hydrophobic.
Figure 7. (A) FTIR spectra for BIF at pH 1.6, 60 °C, 1 M urea, 0.02
M NaCl collected at t = 0 day (−) and t = 42 days (--) showing the
shift in the amide I region. (B) Second-derivative spectra for BIF at
pH 1.6, 60 °C, 1 M urea, 0.02 M NaCl collected at the end of week 1
(−) and its curve-fitted peaks.
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comparison with ThT data shows that the β-sheet increase
occurs mostly during the lag times (12 days for BIF and 21
days for HIF). Thus, the progression of lag phase to the
elongation phase in both the fragments can be assigned to the
increase in the number of β-sheets and their extension to form
fibril.
The samples HIF at pH 1.6, 25 °C, 1 M urea, 1 M NaCl and
at pH 5, 25 °C, 1 M urea, 0.02 M NaCl are still in the lag phase
at the end of the experiment, they have β-sheet contents of
25.1 and 24.6%, respectively. There is no specific criterion as to
how much of β-sheet percentage qualifies to be an amyloid
fibril. According to ThT data, HIF at pH 5, 25 °C, 0 M urea, 1
M NaCl forms fibrils, whereas HIF at pH 1.6, 25 °C, 1 M urea,
1 M NaCl and at pH 5, 25 °C, 1 M urea, 0.02 M NaCl do not;
despite the fact that both peptides reach an almost identical
percentage of β-sheets. Although there is an increase in the β-
sheet content with time for the rest of the runs, these two runs
have a constant β-sheet content. These results are consistent
with the ThT data (Figure 3).
The data shown in Figures 8 and 9 were normalized and
fitted with
= − βy K1 ( )t (2)
where y is the normalized β-sheet percentage, t is the time in
weeks, and Kβ is the rate of increase in β-sheets. Figure 10A,B
Figure 8. Evolution of the intermolecular β-sheets (%) with time
(weeks) for BIF at pH 1.6, 25 °C, 0 M urea, 0.02 M NaCl (−■−);
pH 1.6, 25 °C, 1 M urea, 1 M NaCl (--●--); pH 1.6, 60 °C, 0 M urea,
1 M NaCl (▲); pH 1.6, 60 °C, 1 M urea, 0.02 M NaCl (-·-▼-·-); pH
5, 25 °C, 0 M urea, 1 M NaCl (-··⧫-··); pH 5, 25 °C, 1 M urea, 0.02
M NaCl (----◀----); pH 5, 60 °C, 0 M urea, 0.02 M NaCl (▶); pH
5, 60 °C, 1 M urea, 1 M NaCl (⬢).
Figure 9. Evolution of the intermolecular β-sheets (%) with time
(weeks) for HIF at pH 1.6, 25 °C, 0 M urea, 0.02 M NaCl (−■−);
pH 1.6, 25 °C, 1 M urea, 1 M NaCl (−●−); pH 1.6, 60 °C, 0 M urea,
1 M NaCl (−▲−); pH 1.6, 60 °C, 1 M urea, 0.02 M NaCl (−▼−);
pH 5, 25 °C, 0 M urea, 1 M NaCl (−⧫−); pH 5, 25 °C, 1 M urea,
0.02 M NaCl (−◀−); pH 5, 60 °C, 0 M urea, 0.02 M NaCl (−▶−);
pH 5, 60 °C, 1 M urea, 1 M NaCl (−⬢−).
Figure 10. Curve-fitted plots for the evolution of the intermolecular
β-sheets (%) with time (weeks) for (A) BIF and (B) HBF at pH 1.6,
25 °C, 0 M urea, 0.02 M NaCl (−■−); pH 1.6, 25 °C, 1 M urea, 1 M
NaCl (--●--); pH 1.6, 60 °C, 0 M urea, 1 M NaCl (▲); pH 1.6, 60
°C, 1 M urea, 0.02 M NaCl (-·-▼-·-); pH 5, 25 °C, 0 M urea, 1 M
NaCl (-··⧫-··); pH 5, 25 °C, 1 M urea, 0.02 M NaCl (----◀----) pH 5,
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shows the curve-fitted β-sheet plots for BIF and HIF,
respectively. All of the fitted curves have an R2 value of at
least 97%. The Kβ values calculated for BIF and HIF are shown
in Table 4. Kβ values for BIF are similar for all of the runs, but
the Kβ values for HIF are larger at 60 °C than at 25 °C. At 25
°C, the rate of increase in β-sheets was higher in BIF than HIF,
whereas at 60 °C, the rates were similar. The Kβ value
decreased with an increase in both urea and NaCl
concentrations irrespective of other conditions. Using Kβ as
an outcome, Pareto analysis was conducted to determine the
important factors (Figure S10). Temperature and pH are the
most significant factors for HIF, which is also true for the lag
and elongation phases from ThT data (Figures 4B and 5B).
Ionic strength and urea are the most important factors for BIF.
This is also true for BIF during lag phase, but during the
elongation phase, temperature and pH are more important.
Figure 11A,B shows a plot of percentage change in the α-
helix content with time for BIF and HIF, respectively, for all
runs. Both fragments show a decrease in α-helices with time.
Though there is consistent decrease in the α-helix content in
both fragments during the lag phase, a slight increase in α-
helices can be seen during the transition from lag phase to
elongation phase. Formation of α-helical rich intermediates
was also reported previously in the fibrillation of α-
synuclein.55,56
FTIR analysis was also used to distinguish oligomers from
fibrils. Oligomers are rich in antiparallel β-sheets (1695−1680
cm−1), whereas fibrils are rich in parallel β-sheets (1635−1620
cm−1).40 We calculated the β-index i.e., the ratio of (% of turns
+ antiparallel β-sheets) to % of parallel β-sheets using a similar
protocol as previously mentioned.57 The β-index as a function
of time was plotted for both the fragments, as shown in Figure
S17. Its value decreases with increasing time, which shows that
samples rich in antiparallel β-sheets (oligomers) convert to
parallel β-sheet rich fibrils. That transition from antiparallel to
parallel β-sheets confirms that oligomers are the base unit of
fibrillation.
The presence of fibrils was further confirmed using optical
microscope. A recent NMR study shows that Congo red
binding is specific to fibrils.58 The combination of ThT and
Congo red assays minimizes confounding because they are
independent assays.59 Micrographs shown in Figure 12 contain
irregular proteinaceous deposits when stained with Congo red.
These micrographs demonstrate the amyloid properties for
BIF and HIF at pH 1.6, 60 °C, 1 M urea, 0.02 M salt (Figure
12A,B) and pH 5, 60 °C, 0 M urea, 0.02 M salt (Figure
12C,D), respectively. At pH 1.6, BIF forms amyloid plaques
(Figure 12A), whereas HIF forms distinct annular amyloid
aggregates (Figure 12B).60 The maximum fluorescence
intensity (Figures S1 and S2) represents the maximum
aggregation growth. This is higher in HIF compared to BIF
at pH 1.6, which explains the morphological differences.
Similarly, it is the same at pH 5 for both fragments showing
aggregates of similar morphology.
■ CONCLUSIONS
Two peptide fragments of insulin A-chain with subtle
differences in their primary structure were synthesized, and
their fibrillation propensity was studied using fluorescence and
infrared spectroscopy. We found that the bovine insulin
fragments have a shorter lag time in comparison with the
human insulin ones, but for most samples, the exponential
phase rate was faster for HIF than for BIF. Fibrillation kinetics,
which is dependent on pH and temperature, may have been
Table 4. Rate of Increase in β-Sheets (Kβ) Calculated for
Both BIF and HIF
bovine human
run # Kβ (week−1) Kβ (week−1)
1 0.50 ± 0.08 0.43 ± 0.05
2 0.46 ± 0.07 0.34 ± 0.06
3 0.47 ± 0.09 0.51 ± 0.11
4 0.51 ± 0.09 0.49 ± 0.06
5 0.48 ± 0.08 0.42 ± 0.06
6 0.49 ± 0.07 0.40 ± 0.02
7 0.52 ± 0.04 0.60 ± 0.05
8 0.42 ± 0.08 0.58 ± 0.07
Figure 11. α-Helix percentage changes for (A) BIF and (B) HIF at
pH 1.6, 25 °C, 0 M urea, 0.02 M NaCl (−■−); pH 1.6, 25 °C, 1 M
urea, 1 M NaCl (−●−); pH 1.6, 60 °C, 0 M urea, 1 M NaCl (−▲−);
pH 1.6, 60 °C, 1 M urea, 0.02 M NaCl (−▼−); pH 5, 25 °C, 0 M
urea, 1 M NaCl (−⧫−); pH 5, 25 °C, 1 M urea, 0.02 M NaCl
(−◀−); pH 5, 60 °C, 0 M urea, 0.02 M NaCl (−▶−); pH 5 60 °C,
1 M urea, 1 M NaCl (−⬢−).
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affected by the presence of an Fmoc-attached peptide. An
increase in β-sheets content with time was observed in both
fragments. The increase in β-sheets was preceded by an initial
decrease in α-helices followed by an intermediate increase
during the transition from the lag phase to elongation phase.
The conversion of oligomer structures rich in antiparallel β-
sheets to fibrils rich in parallel β-sheets is a characteristic of
amyloid. The observed α-helix to β-sheet transition as well as
the micrographs obtained using Congo red staining confirmed
the formation of ringlike oligomer structures rich in antiparallel
β-sheets, which then form fibrils rich in parallel β-sheets.
■ EXPERIMENTAL SECTION
Materials. All Fmoc amino acids, Wang resin and (2-(1H-
benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophos-
phate) (HBTU) were purchased from CSBIO Co. ThT was
purchased from Acros Organics. Piperidine, dimethylforma-
mide (DMF), trifluoroacetic acid (TFA), N,N-diisopropyle-
thylamine (DIPEA), and deuterium oxide; 99.9 atom %
deuterium (D) were purchased from Sigma-Aldrich. All other
solvents were purchased from Fischer Scientific.
Peptide Synthesis. The peptides BIF and HIF were
synthesized in a CSBio 336 peptide synthesizer using Fmoc
technique in solid-phase peptide synthesis.61 Wang resin (0.5
mmol/g) was used as a solid support matrix for this purpose,
and the synthesis was carried out from the C- to the N-
terminus.62 One millimole per synthesis of each Fmoc amino
acid was used. Deprotection of Fmoc group was done using
20% piperidine in DMF. HBTU combined with DIPEA was
used as an activator to facilitate the coupling of amino acids.
The complete synthesis took approximately 18 h. The product
from the reaction vessel was suspended in dichloromethane,
and the peptide was cleaved from the swollen resin using 95%
TFA. The cleaved peptide was then resuspended in cold
diethyl ether and centrifuged twice using RC-3B refrigerated
centrifuge (Sorvall Instruments) at 4650g, −5 °C for 30 min.
The obtained pellet was dissolved in 10 mM acetic acid and
lyophilized to obtain the final peptide fragment.
NMR Spectroscopy. The amino acid composition of the
peptides was confirmed using liquid state one-dimensional 1H
NMR spectroscopy. Samples for the analysis were prepared by
dissolving 10 mg of the peptide in 750 μL D2O (99.9%
deuterium). Spectra were obtained using a Bruker 400 MHz
spectrometer equipped with a BBO probe. 1H NMR data were
obtained with a sweep width of 3997.8 MHz, 0.256 s
acquisition time, 16 scans, and a 2 s recycle delay.
Mass Spectrometry. To determine the purity and the
mass of the peptides, LC−MS data were acquired on an
Agilent 6520 Q-TOF LC−MS system. Lyophilized peptides
were suspended in 0.1% formic acid in water to obtain a final
concentration of 1 mg/mL. Five microliter of the sample was
loaded on an Agilent Technologies 43 mm C18 Chip column.
Agilent Technologies 1200 Series Quaternary high-perform-
ance liquid chromatograph was used. LC gradient: initial
conditions 3% B (A: 0.1% formic acid in water; B: 99.9%
acetonitrile, 0.1% formic acid), gradient to 80% B over 9 min,
hold at 80% B for 3 min, ramp back to (0.5 min) and hold at
(2.5 min) initial conditions. An Agilent Technologies 6520A
Accurate Mass Q-TOF MS with integrated Chip Cube source
was used to collect data. Data across a total of 15 min of
Figure 12. Micrographs showing the presence of fibrils for (A) BIF at pH 1.6, 60 °C, 1 M urea, 0.02 M NaCl, (B) HIF at pH 1.6, 60 °C, 1 M urea,
0.02 M NaCl, (C) BIF at pH 5, 60 °C, 0 M urea, 0.02 M NaCl, and (D) HIF at pH 5, 60 °C, 0 M urea, 0.02 M NaCl.
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elution were collected. MS data were collected between 295
and 2500 m/z, and MS/MS data were collected between 70
and 2500 m/z at 2 spectra/s. Peptides with counts >2000 were
picked for MS/MS.
LC−MS for the fibrils was obtained using an LTQ Orbitrap
XL mass spectrometer. Samples were precipitated using ice-
cold acetone. The pellet was recovered by centrifugation (16
000g) and washed twice with 80% acetone (in water). The
pellet was dried and resuspended in 100 μL of urea buffer (6 M
urea, 2 M thiourea, 0.1 M ammonium bicarbonate). No
particulates were observed, suggesting fibrils were completely
dissolved in the buffer.
In Vitro Fibrillation. Samples were prepared with a
peptide concentration of 10 mg/mL. A total of 16 samples,
eight for each fragment varying the experimental conditions
were made. All of the samples were prepared in 0.22 μm
filtered phosphate buffer at their respective pH (1.6 and 5).
Urea and sodium chloride with two different concentrations
were added. Samples were incubated with ThT at two different
temperatures (25 and 60 °C) under stirring and no stirring
conditions. The evolution of the fibrillation process with time
was followed by fluorescence assay, and the changes in
secondary structure were studied using FTIR. The water used
for the preparation of buffers was purified to a resistivity of
17.5 MΩ cm.
ThT Fluorescence Assay. ThT assay was done using a
NanoDrop 3300 Fluorospectrometer (Thermo Fisher Scien-
tific) using white light as the excitation source (460−650 nm).
The emission wavelength was set to 482 nm. Free dye has an
excitation wavelength of 385 nm and an emission wavelength
of 445 nm. A stock solution for the ThT assay was prepared by
adding 0.8 mg of ThT dye to 50 mL of 0.22 μm filtered
phosphate buffer (pH 7) and stored at 4 °C in a dark place to
prevent quenching. ThT solution (0.05 mM) was added to
each sample at the beginning of incubation. A ThT solution
with only the buffer was used as a blank for the assay.
Fluorescence for each sample was recorded every 3 days.
Increase in viscosity or the appearance of gel/precipitate with
time upon visual inspection is a characteristic of the ThT
assay.22 All of the reported fluorescence readings were an
average of five replicates.
FTIR Analysis. Analysis was carried out with a Nicolet 6700
FTIR spectrometer from Thermoscientific equipped with a
KBr beam-splitter and a DTGC detector cooled by liquid
nitrogen. A smart performer attenuated total reflectance
sampling accessory with a germanium (Ge) crystal was used.
Interferograms were obtained for each sample at a resolution of
16 cm−1, and 256 scans were collected for each run to obtain a
good signal-to-noise ratio.
Congo Red Staining. Congo red dye was used to stain and
obtain the micrographs of the fibrils. A stock solution was
prepared by adding 7 mg of Congo red to 1 mL of 0.22 μm
filtered water. Samples containing fibrils were first centrifuged
using a microcentrifuge at 9450g and then washed thoroughly
with water. The pellet was then resuspended in 1 mL of water,
and 5 μL of Congo red solution was added and incubated at 25
°C for 1 h. After obtaining a red precipitate, the sample was
centrifuged again. The pellet was washed twice with water to
remove the unattached dye. The fibrils were then resuspended
in a small amount of water. Congo red stained fibrils (30 μL)
were placed on a microscopic slide and air-dried. Micrographs
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